Friday, May 8, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Hospital Mergers Need Patient Involvement

All mergers must balance financial returns with clinical outcomes.

Daily Remedy by Daily Remedy
December 21, 2023
in Financial Markets
0
Hospital Mergers Need Patient Involvement

Tim Gouw

In healthcare, there is an open secret behind the executives who make crucial decisions to engage in a healthcare system merger. They’re rife with conflicts of interest. Corporate culture, shareholder incentives, and the financial value of healthcare mergers all play a role in shaping the corporate culture of executives in healthcare. This culture defines the administrative system that oversees patient care.

The incentive structures within this system are less than fully altruistic, though you wouldn’t know it by the rhetoric espoused. Whenever we hear of hospital systems and health plans engaging in mergers, we’re usually filled with aspirational truisms that never prove to be true. They claim such actions will improve the patient experience or help providers connect with patients. However, it is important to remain grounded in reality and know how to hold these companies accountable for their claims. Remember, all that glitters is not gold. And you don’t want to be the one stuck with the fool’s gold.

As a patient, immerse yourself in learning the culture of the healthcare system in which you receive care. The culture within an organization greatly influences the decision-making process and the values that guide those decisions. Healthcare executives who lead the organization have the power to shape the quality of patient care.

However, as patients, it’s difficult to see if the system through which you’re experiencing healthcare is serving your medical needs.

One way to assess corporate culture is to examine the incentives that healthcare executives receive. Shareholder incentives can heavily influence the decision-making process, as executives may be driven to prioritize short-term financial gain over long-term patient well-being. This can lead to decisions that may not be in the best interest of patients.

Shareholders often prioritize financial gains and increased market value over other considerations, such as patient care quality or access to services. This can create a situation where the primary focus of a merger is to generate profit, rather than improve healthcare outcomes.

Healthcare mergers that lead to increased consolidation and reduced competition may be good for a health system’s bottom line. However, potential limitations on patient choice may lead to worse patient outcomes that adversely affect the accessibility and affordability of healthcare, particularly for vulnerable populations.

It is important to closely examine the incentives that drive healthcare mergers and critically assess their potential impact on patient care. By understanding the financial motivations behind these mergers, we can better advocate for policies that prioritize patient well-being and ensure that healthcare executives are accountable for the decisions they make.

One of the main goals of healthcare mergers is to increase efficiency and reduce costs. By consolidating resources and streamlining operations, healthcare organizations aim to achieve economies of scale. This, in turn, can lead to improved financial performance and profitability. Sometimes this can be good for patient care; other times, less so.

While financial gains are a crucial aspect of any business, we must also consider the potential consequences of prioritizing profits in the healthcare sector. The pursuit of financial value should not come at the expense of patient care quality and accessibility.

It is essential to assess the true financial value of healthcare mergers by looking beyond short-term gains and scrutinizing their long-term impact on patient outcomes. Understanding the relationship between financial value and patient well-being is paramount. Often that perspective is best appreciated by the patients affected. As a result, patients should be consulted and involved whenever a hospital merger takes place.

In order to navigate the complex world of healthcare mergers successfully, healthcare executives should involve patients. Such a collaborative approach will produce a more effective integration strategy. These collaborative strategies will help mitigate risks, maximize benefits, and ensure a smooth transition for all stakeholders involved, both in the short-term and long-term.

So if your health system is undergoing or recently went through a merger, as a patient, examine the process through the following factors:

Were there clearly defined strategic objectives?

Before initiating a merger, healthcare executives should clearly define the strategic objectives they hope to achieve. This includes identifying specific goals, such as expanding services, improving patient care, or entering new markets. By having a clear vision, executives can align their actions and decisions with these objectives.

Did leadership conduct thorough and transparent due diligence?

A comprehensive due diligence process is crucial to assessing the potential risks and rewards of a merger. This involves thoroughly evaluating the financial health, operational efficiency, and cultural compatibility of the target organization. Gathering accurate and relevant data will enable executives to make informed decisions and better understand the long-term implications of the merger.

Was there a detailed integration plan that included all stakeholders?

The merger process requires a well-planned integration strategy. Key elements of this plan include efficient alignment of systems and processes, effective communication with employees and stakeholders, and establishing a unified corporate culture. Developing a detailed integration plan will help healthcare executives navigate the complexities of merging organizations and ensure a seamless transition.

Did leadership prioritize patient care and clinical outcomes?

Leadership plays a critical role in guiding and managing change during a merger. Healthcare executives must provide clear direction, communicate openly and transparently with patients, and actively manage any change that disrupts the balance between financial returns and patient outcomes. By prioritizing effective leadership and long-term patient outcomes, executives can reduce uncertainty and foster a positive transition experience.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Geographic Price Dispersion as a Macro Signal: What Hospital Rate Variance Tells Investors About Regional Economic Health

    The Gross-to-Net Bubble

    0 shares
    Share 0 Tweet 0
  • Why Procurement Teams Now Study Failure Before Features

    0 shares
    Share 0 Tweet 0
  • The Unit Problem Nobody Wants to Fix

    0 shares
    Share 0 Tweet 0
  • Nonlinear Healthcare Models

    0 shares
    Share 0 Tweet 0
  • A Two Headed Monster – State Attorneys General and the Drug Enforcement Agency

    3 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy